Biomarkers of food intake for cocoa and liquorice (products): A systematic review

Genes and Nutrition

Volumn 13, Issue 1, 2018, Pages

  Michielsen, Charlotte C J R ^a   Almanza Aguilera, Enrique ^b,c   Brouwer Brolsma, Elske M ^a   Urpi Sarda, Mireia ^b,c   Afman, Lydia A ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Unidad de Gestión Clínica de Laboratorios Clínicos   (Spain)

Author keywords

Biomarkers; Cacao; Chocolate; Cocoa; Licorice; Liquorice; Metabolites; Metabolomics

Indexed keywords

18 GLYCYRRHETINIC ACID; 18 GLYCYRRHETINIC ACID GLUCURONIDE; 3BETA MONOGLUCURONYL 18BETA GLYCYRRHETINIC ACID; BIOLOGICAL MARKER; CAFFEINE; CATECHIN; EPICATECHIN; GLABRIDIN; GLYCYRRHETINIC ACID; GLYCYRRHIZA GLABRA ROOT; METHYLXANTHINE; POLYPHENOL; UNCLASSIFIED DRUG;

CACAO; CHOCOLATE; COCOA BEVERAGE; COFFEE; EVALUATION STUDY; FOOD COMPOSITION; FOOD INTAKE; GLYCYRRHIZA GLABRA; HUMAN; LICORICE (CONFECTIONARY); METABOLITE; REVIEW; SYSTEMATIC REVIEW; TEA; VALIDATION STUDY;

EID: 85050621845     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1186/s12263-018-0610-x     Document Type: Review

References (98)

1. Buijsse B, Feskens EM, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med. 2006;166:411-7.
2. Alkerwi AA, Sauvageot N, Crichton GE, Elias MF, Stranges S. Daily chocolate consumption is inversely associated with insulin resistance and liver enzymes in the Observation of Cardiovascular Risk Factors in Luxembourg study. Br J Nutr. 2016;115:1661-8.
3. Djousse L, Hopkins PN, Arnett DK, Pankow JS, Borecki I, North KE, et al. Chocolate consumption is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the NHLBI Family Heart Study. Clin Nutr. 2011;30:38-43.
4. Buijsse B, Weikert C, Drogan D, Bergmann M, Boeing H. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J. 2010;31:1616-23.
5. Janszky I, Mukamal K, Ljung R, Ahnve S, Ahlbom A, Hallqvist J. Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med. 2009;266:248-57.
6. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95:740-51.
7. Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol. 2005;99:317-24.
8. Xiaoying W, Han Z, Yu W: Glycyrrhiza glabra (Licorice): ethnobotany and health benefits. In Sustained energy for enhanced human functions and activity. United States: Elsevier; 2018: 231-50.
9. Johnson L, Mander AP, Jones LR, Emmett PM, Jebb SA. Energy-dense, low-fiber, high-fat dietary pattern is associated with increased fatness in childhood. Am J Clin Nutr. 2008;87:846-54.
10. Nishida C, Uauy R, Kumanyika S, Shetty P. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr. 2004;7:245-50.
11. Van Uum SH. Liquorice and hypertension. Neth J Med. 2005;63:119-20.
12. Shintani S, Murase H, Tsukagoshi H, Shiigai T. Glycyrrhizin (licorice)-induced hypokalemic myopathy. Eur Neurol. 1992;32:44-51.
13. Favé G, Beckmann M, Lloyd AJ, Zhou S, Harold G, Lin W, et al. Development and validation of a standardized protocol to monitor human dietary exposure by metabolite fingerprinting of urine samples. Metabolomics. 2011;7:469-84.
14. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet. 2009;125:507-25.
15. Brennan L, Gibbons H, O'Gorman A. An overview of the role of metabolomics in the identification of dietary biomarkers. Curr Nutr Reports. 2015;4:304-12.
16. O'Gorman A, Gibbons H, Brennan L. Metabolomics in the identification of biomarkers of dietary intake. Comput Struct Biotechnol J. 2013;4:e201301004.
17. Dragsted LO, Gao Q, Praticò G, Manach C, Wishart DS, Scalbert A, et al. Dietary and health biomarkers-time for an update. Genes Nutr. 2017;12:24.
18. Gao Q, Praticò G, Scalbert A, Vergères G, Kolehmainen M, Manach C, et al. A scheme for a flexible classification of dietary and health biomarkers. Genes Nutr. 2017;12:34.
19. Glavac NK, Kreft S. Excretion profile of glycyrrhizin metabolite in human urine. Food Chem. 2012;131:305-8.
20. Lloyd AJ, Favé G, Beckmann M, Lin W, Tailliart K, Xie L, et al. Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods. Am J Clin Nutr. 2011;94:981-91.
21. Scalbert A, Brennan L, Manach C, Andres-Lacueva C, Dragsted LO, Draper J, et al. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014;99:1286-308.
22. Praticò G, Gao Q, Scalbert A, Vergères G, Kolehmainen M, Manach C, et al. Guidelines for Biomarker of Food Intake Reviews (BFIRev): how to conduct an extensive literature search for biomarker of food intake discovery. Genes Nutr. 2018;13:3.
23. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.
24. Ottaviani JI, Borges G, Momma TY, Spencer JPE, Keen CL, Crozier A, et al. The metabolome of 2-C-14 (-)-epicatechin in humans: implications for the assessment of efficacy, safety, and mechanisms of action of polyphenolic bioactives. Sci Rep. 2016;6:29304/1-29304/10
25. Dragsted LO, Gao Q, Scalbert A, Vergères G, Kolehmainen M, Manach C, et al. Validation of biomarkers of food intake-critical assessment of candidate biomarkers. Genes Nutr. 2018;13:14.
26. Edmands WM, Ferrari P, Rothwell JA, Rinaldi S, Slimani N, Barupal DK, et al. Polyphenol metabolome in human urine and its association with intake of polyphenol-rich foods across European countries. Am J Clin Nutr. 2015;102:905-13.
27. Garcia-Aloy M, Llorach R, Urpi-Sarda M, Jauregui O, Corella D, Ruiz-Canela M, et al. A metabolomics-driven approach to predict cocoa product consumption by designing a multimetabolite biomarker model in free-living subjects from the PREDIMED study. Mol Nutr Food Res. 2015;59:212-20.
28. Garrido I, Urpi-Sarda M, Monagas M, Gómez-Cordovés C, Martín-Álvarez PJ, Llorach R, et al. Targeted analysis of conjugated and microbial-derived phenolic metabolites in human urine after consumption of an almond skin phenolic extract-3. J Nutr. 2010;140:1799-807.
29. Urpi-Sarda M, Garrido I, Monagas M, Gómez-Cordovés C, Medina-Remón A, Andres-Lacueva C, et al. Profile of plasma and urine metabolites after the intake of almond [Prunus dulcis (Mill.) D.A. Webb] polyphenols in humans. J Agric Food Chem. 2009;57:10134-42.
30. Fraga CG. Plant phenolics and human health. Hoboken: John Wiley and Sons, Inc.; 2010.
31. El-Seedi HR, El-Said AMA, Khalifa SAM, Göransson U, Bohlin L, Borg-Karlson A-K, et al. Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids. J Agric Food Chem. 2012;60:10877-95.
32. Stark T, Lang R, Keller D, Hensel A, Hofmann T. Absorption of N-phenylpropenoyl-L-amino acids in healthy humans by oral administration of cocoa (Theobroma cacao). Mol Nutr Food Res. 2008;52:1201-14.
33. Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C. Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013;57:962-73.
34. Llorach-Asuncion R, Jauregui O, Urpi-Sarda M, Andres-Lacueva C. Methodological aspects for metabolome visualization and characterization: a metabolomic evaluation of the 24 h evolution of human urine after cocoa powder consumption. J Pharm Biomed Anal. 2010;51:373-81.
35. Peters BA, Hall MN, Liu X, Parvez F, Siddique AB, Shahriar H, et al. Low-dose creatine supplementation lowers plasma guanidinoacetate, but not plasma homocysteine, in a double-blind, randomized, placebo-controlled trial-3. J Nutr. 2015;145:2245-52.
36. Hjerpsted JB, Ritz C, Schou SS, Tholstrup T, Dragsted LO. Effect of cheese and butter intake on metabolites in urine using an untargeted metabolomics approach. Metabolomics. 2014;10:1176-85.
37. Patel KP, Luo FJG, Plummer NS, Hostetter TH, Meyer TW. The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol. 2012;7:982-8.
38. O'Sullivan A, Gibney MJ, Brennan L. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr. 2010;93:314-21.
39. Heinzmann SS, Merrifield CA, Rezzi S, Kochhar S, Lindon JC, Holmes E, et al. Stability and robustness of human metabolic phenotypes in response to sequential food challenges. J Proteome Res. 2011;11:643-55.
40. Heinzmann SS, Holmes E, Kochhar S, Nicholson JK, Schmitt-Kopplin P. 2-Furoylglycine as a candidate biomarker of coffee consumption. J Agric Food Chem. 2015;63:8615-21.
41. Yamamoto K, Hayashi M, Murakami Y, Araki Y, Otsuka Y, Kashiwagi T, et al. Development of LC-MS/MS analysis of cyclic dipeptides and its application to tea extract. Biosci Biotechnol Biochem. 2016;80:172-7.
42. Gautschi M, Schmid JP, Peppard TL, Ryan TP, Tuorto RM, Yang X. Chemical characterization of diketopiperazines in beer. J Agric Food Chem. 1997;45:3183-9.
43. Lipton WE, Li Y-N, Younoszai MK, Stegink LD. Intestinal absorption of aspartame decomposition products in adult rats. Metabolism. 1991;40:1337-45.
44. Llorach R, Urpi-Sarda M, Jauregui O, Monagas M, Andres-Lacueva C. An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. J Proteome Res. 2009;8:5060-8.
45. Larsson K, Bjorklund KL, Palm B, Wennberg M, Kaj L, Lindh CH, et al. Exposure determinants of phthalates, parabens, bisphenol A and triclosan in Swedish mothers and their children. Environ Int. 2014;73:323-33.
46. Ackerman JM, Dodson RE, Engel CL, Gray JM, Rudel RA. Temporal variability of urinary di (2-ethylhexyl) phthalate metabolites during a dietary intervention study. J Expo Sci Environ Epidemiol. 2014;24:595.
47. Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev. 2001;33:125-47.
48. Makino T. 3-Monoglucuronyl glycyrrhretinic acid is a possible marker compound related to licorice-induced pseudoaldosteronism. Biol Pharm Bull. 2014;37:898-902.
49. Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, et al. Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab. 2012;3:125-38.
50. Ploeger B, Mensinga T, Sips A, Meulenbelt J, DeJongh J. A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Pharm Res. 2000;17:1516-25.
51. Krahenbuhl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab. 1994;78:581-5.
52. Kerstens MN, Guillaume CPF, Wolthers BG, Dullaart RPF. Gas chromatographic-mass spectrometric analysis of urinary glycyrrhetinic acid: an aid in diagnosing liquorice abuse. J Intern Med. 1999;246:539-47.
53. Albermann ME, Musshoff F, Hagemeier L, Madea B. Determination of glycyrrhetic acid after consumption of liquorice and application to a fatality. Forensic Sci Int. 2010;197:35-9.
54. Heilman P, Heide J, Hundertmark S, Schöneshöfer M. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine. Exp Clin Endocrinol Diabetes. 1999;107:370-8.
55. Raggi MA, Maffei F, Bugamelli F, Cantelli Forti G. Bioavailability of glycyrrhizin and licorice extract in rat and human plasma as detected by a HPLC method. Pharmazie. 1994;49:269-72.
56. Aoki F, Nakagawa K, Kitano M, Ikematsu H, Nakamura K, Yokota S, et al. Clinical safety of licorice flavonoid oil (lfo) and pharmacokinetics of glabridin in healthy humans. J Am Coll Nutr. 2007;26:209-18.
57. Actis-Goretta L, Leveques A, Giuffrida F, Destaillats F, Nagy K. Identification of O-methyl-(-)-epicatechin-O-sulphate metabolites by mass-spectrometry after O-methylation with trimethylsilyldiazomethane. J Chromatogr A. 2012;1245:150-7.
58. Actis-Goretta L, Lévèques A, Giuffrida F, Romanov-Michailidis F, Viton F, Barron D, et al. Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic Biol Med. 2012;53:787-95.
59. Andersen MBS, Kristensen M, Manach C, Pujos-Guillot E, Poulsen SK, Larsen TM, et al. Discovery and validation of urinary exposure markers for different plant foods by untargeted metabolomics. Anal Bioanal Chem. 2014;406:1829-44.
60. Andersen MB, Rinnan A, Manach C, Poulsen SK, Pujos-Guillot E, Larsen TM, et al. Untargeted metabolomics as a screening tool for estimating compliance to a dietary pattern. J Proteome Res. 2014;13:1405-18.
61. Baba S, Osakabe N, Yasuda A, Natsume M, Takizawa T, Nakamura T, et al. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res. 2000;33:635-41.
62. Holt RR, Lazarus SA, Sullards MC, Zhu QY, Schramm DD, Hammerstone JF, et al. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002;76:798-804.
63. Ito H, Gonthier MP, Manach C, Morand C, Mennen L, Remesy C, et al. Polyphenol levels in human urine after intake of six different polyphenol-rich beverages. Br J Nutr. 2005;94:500-9.
64. Martin FP, Montoliu I, Nagy K, Moco S, Collino S, Guy P, et al. Specific dietary preferences are linked to differing gut microbial metabolic activity in response to dark chocolate intake. J Proteome Res. 2012;11:6252-63.
65. Martínez-López S, Sarriá B, Gómez-Juaristi M, Goya L, Mateos R, Bravo-Clemente L. Theobromine, caffeine, and theophylline metabolites in human plasma and urine after consumption of soluble cocoa products with different methylxanthine contents. Food Res Int. 2014;63:446-55.
66. Mullen W, Borges G, Donovan JL, Edwards CA, Serafini M, Lean ME, et al. Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am J Clin Nutr. 2009;89:1784-91.
67. Neilson AP, George JC, Janle EM, Mattes RD, Rudolph R, Matusheski NV, et al. Influence of chocolate matrix composition on cocoa flavan-3-ol bioaccessibility in vitro and bioavailability in humans. J Agric Food Chem. 2009;57:9418-26.
68. Ottaviani JI, Balz M, Kimball J, Ensunsa JL, Fong R, Momma TY, et al. Safety and efficacy of cocoa flavanol intake in healthy adults: a randomized, controlled, double-masked trial. Am J Clin Nutr. 2015;102:1425-35
69. Ottaviani JI, Momma TY, Kuhnle GK, Keen CL, Schroeter H. Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic Biol Med. 2012;52:1403-12.
70. Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, Fraga CG. Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr. 2000;130:2109s-14s.
71. Richelle M, Tavazzi I, Enslen M, Offord EA. Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr. 1999;53:22-6.
72. Rios LY, Bennett RN, Lazarus SA, Rémésy C, Scalbert A, Williamson G. Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr. 2002;76:1106-10.
73. Rios LY, Gonthier MP, Remesy C, Mila I, Lapierre C, Lazarus SA, et al. Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am J Clin Nutr. 2003;77:912-8.
74. Ritter C, Zimmermann BF, Galensa R. Chiral separation of (+)/(-)-catechin from sulfated and glucuronidated metabolites in human plasma after cocoa consumption. Anal Bioanal Chem. 2010;397:723-30.
75. Rodriguez-Mateos A, Cifuentes-Gomez T, Gonzalez-Salvador I, Ottaviani JI, Schroeter H, Kelm M, et al. Influence of age on the absorption, metabolism, and excretion of cocoa flavanols in healthy subjects. Mol Nutr Food Res. 2015;59:1504-12.
76. Rodriguez-Mateos A, Oruna-Concha MJ, Kwik-Uribe C, Vidal A, Spencer JP. Influence of sugar type on the bioavailability of cocoa flavanols. Br J Nutr. 2012;108:2243-50.
77. Roura E, Almajano MP, Bilbao MLM, Andrés-Lacueva C, Estruch R, Lamuela-Raventós RM. Human urine: epicatechin metabolites and antioxidant activity after cocoa beverage intake. Free Radic Res. 2007;41:943-9.
78. Roura E, Andres-Lacueva C, Estruch R, Lourdes Mata Bilbao M, Izquierdo-Pulido M, Lamuela-Raventos RM. The effects of milk as a food matrix for polyphenols on the excretion profile of cocoa (-)-epicatechin metabolites in healthy human subjects. Br J Nutr. 2008;100:846-51.
79. Roura E, Andrés-Lacueva C, Jáuregui O, Badia E, Estruch R, Izquierdo-Pulido M, et al. Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma (-)-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J Agric Food Chem. 2005;53:6190-4.
80. Roura E, Andres-Lacueva C, Estruch R, Mata-Bilbao ML, Izquierdo-Pulido M, Waterhouse AL, et al. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann Nutr Metab. 2007;51:493-8.
81. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A. 2006;103:1024-9.
82. Shively CA, Tarka SM, Arnaud MJ, Dvorchik BH, Passananti GT, Vesell ES. High levels of methylxanthines in chocolate do not alter theobromine disposition. Clin Pharmacol Ther. 1985;37:415-24.
83. Urpi-Sarda M, Llorach R, Khan N, Monagas M, Rotches-Ribalta M, Lamuela-Raventos R, et al. Effect of milk on the urinary excretion of microbial phenolic acids after cocoa powder consumption in humans. J Agric Food Chem. 2010;58:4706-11.
84. Urpi-Sarda M, Monagas M, Khan N, Lamuela-Raventos RM, Santos-Buelga C, Sacanella E, et al. Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats. Anal Bioanal Chem. 2009;394:1545-56.
85. Urpi-Sarda M, Monagas M, Khan N, Llorach R, Lamuela-Raventós RM, Jáuregui O, et al. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2009;1216:7258-67.
86. Vitaglione P, Barone Lumaga R, Ferracane R, Sellitto S, Morello JR, Reguant Miranda J, et al. Human bioavailability of flavanols and phenolic acids from cocoa-nut creams enriched with free or microencapsulated cocoa polyphenols. Br J Nutr. 2013;109:1832-43.
87. Ibero-Baraibar I, Romo-Hualde A, Gonzalez-Navarro CJ, Zulet MA, Martinez JA. The urinary metabolomic profile following the intake of meals supplemented with a cocoa extract in middle-aged obese subjects. Food Funct. 2016;7:1924-31.
88. Appeldoorn MM, Vincken J-P, Aura A-M, Hollman PCH, Gruppen H. Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J Agric Food Chem. 2009;57:1084-92.
89. Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Asp Med. 2010;31:446-67.
90. Monagas M, Urpi-Sarda M, Sanchez-Patan F, Llorach R, Garrido I, Gomez-Cordoves C, et al. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010;1:233-53.
91. Cornish HH, Christman A. A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem. 1957;228:315-23.
92. Damm I, Enger E, Chrubasik-Hausmann S, Schieber A, Zimmermann BF. Fast and comprehensive analysis of secondary metabolites in cocoa products using ultra high-performance liquid chromatography directly after pressurized liquid extraction. J Sep Sci. 2016;39:3113-22.
93. Jang S, Sun J, Chen P, Lakshman S, Molokin A, Harnly JM, et al. Flavanol-enriched cocoa powder alters the intestinal microbiota, tissue and fluid metabolite profiles, and intestinal gene expression in pigs. J Nutr. 2016;146:673-80.
94. Langer S, Marshall LJ, Day AJ, Morgan MRA. Flavanols and methylxanthines in commercially available dark chocolate: a study of the correlation with nonfat cocoa solids. J Agric Food Chem. 2011;59:8435-41.
95. Garcia-Aloy M, Rabassa M, Casas-Agustench P, Hidalgo-Liberona N, Llorach R, Andres-Lacueva C. Novel strategies for improving dietary exposure assessment: multiple-data fusion is a more accurate measure than the traditional single-biomarker approach. Trends Food Sci Technol. 2017;69:220-9.
96. Scientific Committee on Food EC, Health and Consumer Protection Directorate General.: Opinion of the Scientific Committee on Food on glycyrrhizic acid and its ammonium salt. 2003. https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out186_en.pdf (Accessed 8 June 2018), 10 April 2003.
97. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med. 1997;23:302-13.
98. FoodComEx. 2017. http://foodcomex.org/. Accessed 11 June 2017.